본문으로 건너뛰기
← 뒤로

Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML).

1/5 보강
Stem cells translational medicine 2025 Vol.14(12)
Retraction 확인
출처

Mutti S, Cavalleri A, Sicuranza A, Pacelli P, Ielo C, Paolini L

📝 환자 설명용 한 줄

Chronic myeloid leukemia (CML) persists due to leukemic stem cells, notably the CD26+ subset.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Mutti S, Cavalleri A, et al. (2025). Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML).. Stem cells translational medicine, 14(12). https://doi.org/10.1093/stcltm/szaf062
MLA Mutti S, et al.. "Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML).." Stem cells translational medicine, vol. 14, no. 12, 2025.
PMID 41277535 ↗

Abstract

Chronic myeloid leukemia (CML) persists due to leukemic stem cells, notably the CD26+ subset. We investigated correlations between circulating CD26+ leukemic stem cells (LSCs) and BCR::ABL1 transcripts in an extracellular vesicle-enriched secretome (EVES) from plasma samples of 44 CML patients. EVES were characterized and BCR::ABL1 quantified via digital PCR. We observed an inverse correlation between CD26+LSC counts and EVES BCR::ABL1 levels, especially in deep molecular responders (DMR). CD26+LSCs were elevated in patients in treatment-free remission (TFR), while EVES BCR::ABL1 levels were higher in those receiving therapy. These findings suggest distinct dynamics between LSC populations and vesicle-mediated transcript release, with potential implications for CML monitoring and prognosis.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기